Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 362 participants.
Also called NCT02131220
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 362 participants
- Sponsor
- Registry
-
NCT02131220
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT02131220. Randomized; double masking; primary purpose treatment. Start 2015-11 (actual); primary completion 2017-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction
- Acronym
- ERUPTION
- Condition
- Myocardial Infarction
- Condition
- Percutaneous Coronary Intervention
- Condition
- Thrombolytic Therapy
- Intervention (Drug)
- Prourokinase
- Intervention (Drug)
- Tirofiban
- Intervention (Drug)
- normal saline
- Lead sponsor
- Fudan University
Record details
- Record id
cardio:ct-nct02131220- Content hash
88df6f65c29b5aaea434f41cf74a14b68e8923d445dd1ee58ded83d40683317e